Viewing Study NCT05429905


Ignite Creation Date: 2025-12-25 @ 3:21 AM
Ignite Modification Date: 2025-12-26 @ 1:59 AM
Study NCT ID: NCT05429905
Status: RECRUITING
Last Update Posted: 2023-03-09
First Post: 2021-12-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia
Sponsor: KK Women's and Children's Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module